Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P06126 (
CD1a
)
2,221
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Small plaque parapsoriasis
(
SPP
) is one of the cutaneous T-cell lymphoproliferative disorders. The aim of the present study was to show the antigenic profile of a subset of dendritic cells and lymphocytes in
SPP
in comparison with normal cells to provide data on the role of these two cell types in the pathogenesis of
SPP
. Skin biopsy specimens of lesions were obtained from 8 patients with
SPP
. Biopsies of the healthy skin from 9 control individuals were also analyzed. Immunohistochemistry was performed on the frozen tissue sections to reveal binding of anti-HLA Class II, anti-
CD1a
, anti-CD4, anti-CD8, anti-CD44, anti-CD45, and anti-CD68 monoclonal antibodies. There was a statistically significant increase in the number of
CD1a
(+), Langerhans cells (LCs), HLA-DR-immunoreactive and,
CD1a
-positive dermal dendritic cells and CD68(+) macrophages in the
SPP
group (p=0.008, 0.008, 0.002 and <0.0009, respectively). The number of lymphocytes positive for CD4, CD8 and CD45 was significantly higher than normal in the
SPP
group (p=0.015, <0.0009 and <0.0009, respectively). Our study demonstrates that both peptide- and lipid-based antigens are involved in the persistent antigenic exposure in
SPP
. Dendritic cells play a pivotal role in
SPP
by presenting antigens by both LC and dermal dendritic cells via MHC Class II and
CD1a
molecules. The CD68(+) macrophages are thought to be involved in the immune response in this pathology as an antigen-presenting cell.
...
PMID:Immunohistochemical analysis of small plaque parapsoriasis: involvement of dendritic cells. 1825 85